Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

Abstract Background Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) genomic alterations are rare in prostate cancer (PCa). Gain-of-function mutations lead to overexpression of β-catenin, with consequent hyperactivation of the Wnt/β-catenin signaling pathway, implicated in PCa progression and...

Description complète

Détails bibliographiques

Auteurs principaux:	Dilara Akhoundova, Stefanie Fischer, Joanna Triscott, Marika Lehner, Phillip Thienger, Sina Maletti, Muriel Jacquet, Dinda S.H. Lubis, Lukas Bubendorf, Wolfram Jochum, Mark A. Rubin
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2024-06-01
Collection:	Diagnostic Pathology
Sujets:	Prostate cancer Metastatic castration-resistant prostate cancer (mCRPC) CTNNB1 mutation Wnt/β-catenin pathway Histologic transformation Targeted treatment
Accès en ligne:	https://doi.org/10.1186/s13000-024-01511-3
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!